| Bioactivity | Anticancer agent 250 (compound 104) has antitumor activity, inducing apoptosis, slowing proliferation, and degrading key oncogenic proteins (such as aRaf, CDK4 ) without inducing a heat shock response[1]. |
| Formula | C26H34Cl2N2O3 |
| Molar Mass | 493.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Živa Zajec, et al. New Class of Hsp90 C-Terminal Domain Inhibitors with Anti-tumor Properties against Triple-Negative Breast Cancer. J Med Chem. 2024 Aug 8;67(15):12984-13018. |
Anticancer agent 250
CAS: F: C26H34Cl2N2O3 W: 493.47
Anticancer agent 250 (compound 104) has antitumor activity, inducing apoptosis, slowing proliferation, and degrading key
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.